Skip to main content

We narrowed to 1,580 results for: FLP

Showing: 661 - 680 of 1580 results
  1. EW492 CMV-TO-UTRN-14ZF(N61K,H88F, I91E, K120F)-realdeImmLink-NZF(FLP-IN)

    Plasmid
    #236150
    Purpose
    Express mutated UTRN-14 zinc finger array (N62K, H89F, I91E, K121F) attached by a deimmunized linker to the NZF transcriptional activation under control of CMV promoter with two TetR binding sites
    Depositor
    Insert
    UTRN-14ZF-deImmLink-NZF
    Expression
    Mammalian
    Mutation
    N61K, H88F, I91E, K120F in UTRN-14ZF
    Promoter
    CMV promoter with two TetR binding sites
    Available Since
    April 9, 2025
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-CAG-FlpO (AAV Retrograde)

    Viral Prep
    #183412-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-FlpO (#183412). In addition to the viral particles, you will also receive purified pAAV-CAG-FlpO plasmid DNA. CAG-driven expression of the recombinase FlpO. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Promoter
    CAG
    Available Since
    March 27, 2024
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-Ef1a-fDIO-JRGECO1a (AAV1)

    Viral Prep
    #128317-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO-JRGECO1a (#128317). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-JRGECO1a plasmid DNA. EF1a-driven, Flp-dependent expression of the biosensor jRGECO1a. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    March 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  4. EW482 CMV-TO-ADAR2dd(E488Q, T501A)-PUF-9R-MARIAcomp(V241D, H243M) [D241C, M243Q] (FLP-IN)

    Plasmid
    #236128
    Purpose
    Plasmid encoding ADAR2dd attached to PUF-9R with deimmunizing and function-restoring mutations under control of CMV promoter with two TetR binding sites
    Depositor
    Insert
    ADAR2dd-PUF-9R (ADARB1 Human, Synthetic)
    Expression
    Mammalian
    Mutation
    E488Q, T501A in ADAR2dd; V241C, H243Q in PUF-9R
    Promoter
    CMV promoter with two TetR binding sites
    Available Since
    April 9, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 661 - 680 of 1580 results